Parexel and Veeva Systems are set to accelerate clinical trials through technology and process innovation, as part of a strategic collaboration.

Under the collaboration, the expertise of each company will be combined to improve study efficiency and quickly get new treatments to patients.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Parexel will streamline operations by standardising on Veeva Vault eTMF, Vault CTMS, and Vault Study Startup clinical operations applications.

Parexel will also provide Veeva Vault CDMS for clinical data management as a standard offering to its customers.

Parexel CEO Jamie Macdonald said: “By adopting Veeva’s clinical solutions we will streamline trial processes, drive greater efficiency, and make trial execution and participation easier for sponsors, sites, and patients.

“Through this expanded partnership with Veeva, we expect to deliver greater value for customers and make an even bigger impact on patients’ lives.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The companies will obtain insights from sponsors, sites and patients and collaborate to continuously improve the cloud technology and processes for clinical trials delivery for Veeva and Parexel, respectively.

Parexel will also get early access and provide input into Veeva’s clinical products, which include innovations, for offering support to sites and patients in decentralised clinical trials, risk-based quality management, and community-based sites.

Veeva Systems founder and CEO Peter Gassner said: “We’re proud to partner with Parexel to drive customer success and speed innovations in clinical research.

“Together, we can accelerate how our customers bring new vaccines, diagnostics, devices, and therapies to patients in need.”

Last month, Korean contract research organisation LSK Global Pharma Services adopted Veeva Vault eTMF, Veeva Vault CTMS, and Veeva SiteVault Free clinical applications to streamline the global trial processes.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact